What is the optimum dose of type a botulinum toxin for treating neurogenic bladder overactivity?
Shah
Julian
J
Patki
Prasad
P
Patil
Krishna
K
Wood
Sharon
S
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A